 |
|
The Relationship between Serum VEGF Concentration and Prognosis of Lung Cancer
Seung Ha Park, Seung Sei Lee
Korean J Intern Med. 2003;18(4):207-211. Published online 2003 Dec 1 DOI: https://doi.org/10.3904/kjim.2003.18.4.207
|
|
Citations to this article as recorded by
 mRNA Expression Analysis of E-Cadherin, VEGF, and MMPs in Gastric Cancer: a Pilot Study
Puneet Kumar, Arun Sebastian, Khushi Verma, Ruhi Dixit, Soni Kumari, Juhi Singh, Satyendra Kumar Tiwary, Gopeshwar Narayan
Indian Journal of Surgical Oncology.2021; 12(S1): 85. CrossRef Glucobrassicin Metabolites Ameliorate the Development of Portal Hypertension and Cirrhosis in Bile Duct-Ligated Rats
Ting Chang, Hsin-Ling Ho, Shao-Jung Hsu, Ching-Chih Chang, Ming-Hung Tsai, Teh-Ia Huo, Hui-Chun Huang, Fa-Yauh Lee, Ming-Chih Hou, Shou-Dong Lee
International Journal of Molecular Sciences.2019; 20(17): 4161. CrossRef Expression, prognostic and predictive impact of VEGF and bFGF in non-small cell lung cancer
Fadi S. Farhat, Arafat Tfayli, Najla Fakhruddin, Rami Mahfouz, Zaher K. Otrock, Raafat S. Alameddine, Ahmad H. Awada, Ali Shamseddine
Critical Reviews in Oncology/Hematology.2012; 84(2): 149. CrossRef Serological thymidine kinase 1 is a prognostic factor in oesophageal, cardial and lung carcinomas
Zhishan Li, Yinghong Wang, Jie He, Jie Ma, Liang Zhao, Hengqi Chen, Ning Li, Ji Zhou, Ellen He, Sven Skog
European Journal of Cancer Prevention.2010; 19(4): 313. CrossRef The role of thymidine kinase in cancer diseases
Ondrej Topolcan, Lubos Holubec
Expert Opinion on Medical Diagnostics.2008; 2(2): 129. CrossRef Combining radiotherapy and angiogenesis inhibitors: Clinical trial design
Deborah Citrin, Cynthia Ménard, Kevin Camphausen
International Journal of Radiation Oncology*Biology*Physics.2006; 64(1): 15. CrossRef Angiogenesis in non-small cell lung cancer: The prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood
Roy M. Bremnes, Carlos Camps, Rafael Sirera
Lung Cancer.2006; 51(2): 143. CrossRef
|